Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
MB Raft, ML Hetland, CH Brahe, K Hørslev-Petersen, L Midtbøll Ørnbjerg, P Junker, N Biln, K Stengaard-Pedersen & M Østergaard. (2023) Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial. Scandinavian Journal of Rheumatology 52:4, pages 342-352.
Read now
Read now
Aliki I. Venetsanopoulou, Yannis Alamanos, Paraskevi V. Voulgari & Alexandros A. Drosos. (2022) Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert Review of Clinical Immunology 18:9, pages 923-931.
Read now
Read now
GA Versteeg, LMM Steunebrink, HE Vonkeman, PM Ten Klooster, AE Van Der Bijl & MAFJ Van De Laar. (2022) Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission. Scandinavian Journal of Rheumatology 51:2, pages 87-96.
Read now
Read now
M Ziegelasch, A Boman, K Martinsson, I Thyberg, C Jacobs, BM Nyhäll-Wåhlin, A Svärd, E Berglin, S Rantapää-Dahlqvist, T Skogh & A Kastbom. (2020) Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–2011. Scandinavian Journal of Rheumatology 49:6, pages 434-442.
Read now
Read now
Articles from other publishers (7)
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, Lars Klareskog, Lars Alfredsson, Linda Mathsson-Alm, Monika Hansson, Martin Cornillet, Guy Serre, Rikard Holmdahl, Karl Skriner, Per-Johan Jakobsson, Helga Westerlind, Johan Askling & Johan Rönnelid. (2023) In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the Rheumatic Diseases, pages ard-2023-224728.
Crossref
Crossref
Simone Perniola, Maria Sole Chimenti, Francesca Romana Spinelli, Bruno Frediani, Rosario Foti, Sara Ferrigno, Cristina Garufi, Giulia Cassone, Vincenzo Venerito, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Ennio Giulio Favalli, Florenzo Iannone, Marco Sebastiani, Gian Franco Ferraccioli, Giovanni Lapadula & Elisa Gremese. (2023) Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”. Journal of Clinical Medicine 12:8, pages 2781.
Crossref
Crossref
Marianne A Messelink, Alfons A den Broeder, Florine E Marinelli, Edwin Michgels, P Verschueren, Daniel Aletaha, Janneke Tekstra & Paco M J Welsing. (2023) What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis. RMD Open 9:2, pages e003196.
Crossref
Crossref
Elisa Gremese, Barbara Tolusso, Dario Bruno, Simone Perniola, Gianfranco Ferraccioli & Stefano Alivernini. (2023) The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 – Unmet needs and therapeutic perspectives. Frontiers in Medicine 10.
Crossref
Crossref
Maria V. Sokolova, Georg Schett & Ulrike Steffen. (2021) Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings. Clinical Reviews in Allergy & Immunology 63:2, pages 138-151.
Crossref
Crossref
Dario Bruno, Anna Laura Fedele, Barbara Tolusso, Angelina Barini, Luca Petricca, Clara Di Mario, Antonella Barini, Luisa Mirone, Gianfranco Ferraccioli, Stefano Alivernini & Elisa Gremese. (2021) Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study. Frontiers in Medicine 8.
Crossref
Crossref
Stefano Alivernini, Barbara Tolusso, Anna Laura Fedele, Clara Di Mario, Gianfranco Ferraccioli & Elisa Gremese. (2019) The B side of rheumatoid arthritis pathogenesis. Pharmacological Research 149, pages 104465.
Crossref
Crossref